Antihypertensive therapy for prehypertension relationship with cardiovascular outcomes

JAMA

Volumn 305, Issue 9, 2011, Pages 940-941

  Ventura, Hector O ^a   Lavie, Carl J ^b  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DIASTOLIC BLOOD PRESSURE; EARLY INTERVENTION; EDITORIAL; HEART INFARCTION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; PREHYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 79952222179     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.256     Document Type: Editorial

References (14)

1. Ventura HO, Mehra MR, Messerli FH. Desperate diseases, desperate measures: tackling malignant hypertension in the 1950s. Am Heart J. 2001;142(2):197-203. (Pubitemid 32706273)
2. Frohlich ED. The necessity for recognition and treatment of patients with "mild" hypertension. J Am Coll Cardiol. 1999;34(5):1369-1377.
3. Chobanian AV, Bakris GL, Black HR, et al; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. (Pubitemid 37553153)
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913. (Pubitemid 35472129)
5. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001;358(9294):1682-1686. (Pubitemid 33124327)
6. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287(8):1003-1010. (Pubitemid 34252058)
7. Lloyd-Jones D, Adams RJ, Brown TM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948-954.
8. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control - continued disparities in adults: United States, 2005-2006: NCHS Data Brief 1-8. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/data/databriefs/db03.pdf. 2008. Accessed February 10, 2011.
9. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004;164(19):2113-2118.
10. Grotto I, Grossman E, Huerta M, Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension. 2006;48(2):254-259. (Pubitemid 44309820)
11. White PD. Heart Disease. 2nd ed. New York, NY: Macmillan; 1937:326.
12. Staessen JA, Richart T, Wang Z, Thijs L. Implications of recently published trials of blood pressure-lowering drugs in hypertensive or high-risk patients. Hypertension. 2010;55(4):819-831.
13. Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Anti-hypertensive treatment and secondary prevention of cardiovascular disease events among persons with hypertension: a meta-analysis. JAMA. 2011;305(9):913-922.
14. Pimenta E, Oparil S; Medscape. Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol. 2010;6(1):21-30.